Lam Research Corporation $LRCX Shares Sold by NJ State Employees Deferred Compensation Plan

NJ State Employees Deferred Compensation Plan lessened its holdings in Lam Research Corporation (NASDAQ:LRCX) by 6.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 52,960 shares of the semiconductor company’s stock after selling 3,690 shares during the quarter. Lam Research accounts for approximately 0.8% of NJ State Employees Deferred Compensation Plan’s holdings, making the stock its 15th largest holding. NJ State Employees Deferred Compensation Plan’s holdings in Lam Research were worth $7,091,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. Brighton Jones LLC lifted its position in Lam Research by 1,032.4% during the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock valued at $1,025,000 after purchasing an additional 12,936 shares during the period. Caxton Associates LLP acquired a new position in Lam Research in the first quarter valued at approximately $239,000. Ignite Planners LLC grew its stake in shares of Lam Research by 32.8% during the 2nd quarter. Ignite Planners LLC now owns 5,169 shares of the semiconductor company’s stock worth $520,000 after purchasing an additional 1,277 shares during the period. Harbour Investments Inc. boosted its holdings in Lam Research by 6.3% during the second quarter. Harbour Investments Inc. now owns 3,230 shares of the semiconductor company’s stock worth $314,000 after buying an additional 192 shares in the last quarter. Finally, Chicago Partners Investment Group LLC grew its position in Lam Research by 5.9% during the second quarter. Chicago Partners Investment Group LLC now owns 15,395 shares of the semiconductor company’s stock valued at $1,495,000 after buying an additional 863 shares during the period. Institutional investors and hedge funds own 84.61% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on LRCX. Wells Fargo & Company upped their target price on Lam Research from $250.00 to $290.00 and gave the stock an “overweight” rating in a research note on Thursday, January 29th. Weiss Ratings reiterated a “buy (b)” rating on shares of Lam Research in a research note on Monday, December 29th. Deutsche Bank Aktiengesellschaft boosted their price target on Lam Research from $260.00 to $290.00 and gave the stock a “buy” rating in a research report on Thursday, January 29th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $290.00 target price (up previously from $260.00) on shares of Lam Research in a report on Thursday, January 29th. Finally, Barclays set a $250.00 price objective on shares of Lam Research in a research note on Thursday, January 29th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, Lam Research presently has an average rating of “Moderate Buy” and a consensus price target of $244.88.

Insider Buying and Selling

In other news, Director Eric Brandt sold 35,000 shares of the company’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the transaction, the director owned 253,705 shares in the company, valued at approximately $57,235,848. This represents a 12.12% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 0.31% of the stock is owned by corporate insiders.

Lam Research Price Performance

LRCX opened at $235.53 on Tuesday. The stock’s 50-day moving average price is $203.22 and its 200 day moving average price is $156.73. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $251.87. The firm has a market cap of $294.12 billion, a price-to-earnings ratio of 48.26, a PEG ratio of 2.53 and a beta of 1.78. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, topping the consensus estimate of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The firm had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same period in the prior year, the firm earned $0.91 EPS. The firm’s revenue for the quarter was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, sell-side analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be issued a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s dividend payout ratio is 21.31%.

Lam Research Company Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.